NL-OMON20386招募中不适用
Phenomics & Genomics of Clozapine Pharmacotherapy: Current Users
Dr. J. Luykx0 个研究点目标入组 2,500 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2,500
研究概览
简要总结
one yet
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •he/she currently uses CLZ
- •-he/she has received a diagnosis of schizophrenia, schizophreniform disorder, schizoaffective disorder or psychosis not otherwise specified
排除标准
- •- admission to a psychiatric unit involuntarily in the context of an ‘inbewaringstelling’ (IBS)
- •- a history of Parkinson’s disease
研究者
相似试验
招募中
不适用
A better understanding of the response and side effect of clozapine useSchizophrenia,schizophreniform and schizoaffective disorderClozapine, psychotic disordersNL-OMON20290niversity Medical Center Utrecht60
招募中
不适用
Phenomics & Genomics of Clozapine Pharmacotherapy - Current Userspsychosispsychotic disorders10039628NL-OMON50518niversitair Medisch Centrum Utrecht2,778
撤回
不适用
Phenomics and Genomics of Clozapine Pharmacotherapypsychosispsychotic disorders10039628NL-OMON42072niversitair Medisch Centrum Utrecht4,000
招募中
不适用
Phenomics and Genomics of Clozapine Pharmacotherapy - New Clozapine UsersPsychosispsychotic disorders10039628NL-OMON50475niversitair Medisch Centrum Utrecht200
Unknown
不适用
Phenomics and Genomics of Clozapine PharmacotherapySchizophrenia Spectrum and Other Psychotic DisordersNCT03253367Jurjen Luykx2,500